New Nasal Spray Effective Against All COVID-19 Variants
Novel nasal spray developed by a team of researchers was found to be effective against all variants of COVID and it can offer protection up to 8 hours.
Novel nasal spray developed by a team of researchers was found to be effective against all variants of COVID and it can offer protection up to 8 hours.
‘Ryaltris nasal spray was approved by the US Food and Drug Administration's (FDA) to treat seasonal allergic rhinitis.’
Tweet it Now
"The FDA's approval of Ryaltris represents a major milestone for Glenmark and clearly supports our efforts to bring innovative treatment options in our key therapeutic areas." said Chief Commercial Officer Robert Crockart. Ryaltris will be marketed and distributed in America by Hikma Specialty U.S.A., Inc., as part of its exclusive licensing agreement with Glenmark Specialty S.A.
Glenmark has entered into commercial agreements with several partners around the world, including Menarini for the commercialization of Ryaltris in select EU markets, and with Bausch Health in Canada (where it is under review by Health Canada), the company said.
Trial on New Nasal Spray to Fight COVID-19 Starts
Heparin, a widely used blood-thinning drug to treat or prevent blood clots forms the base of the nasal spray treatment that is simple to administer, stable at room temperature and available globally.
Heparin, a widely used blood-thinning drug to treat or prevent blood clots forms the base of the nasal spray treatment that is simple to administer, stable at room temperature and available globally.
Source-IANS
China Approves Phase 1 Study of COVID Vaccine Administered by Nasal Spray
COVID-19 vaccine administered through nasal spray receives approval in China for Phase I study, reports GlobalData.
COVID-19 vaccine administered through nasal spray receives approval in China for Phase I study, reports GlobalData.
Single Step Naloxone Nasal Spray Can Reduce Opioid Overdose Deaths
Single-step nasal spray Naloxone is the easiest to deliver and has been identified as a key intervention for reducing opioid-related deaths due to overdose.
Single-step nasal spray Naloxone is the easiest to deliver and has been identified as a key intervention for reducing opioid-related deaths due to overdose.
